Corrona® Psoriasis Registry Expands to Canada; Enrolls First Patient

PORTLAND, Ore., Dec. 11, 2017 /CNW/ -- The Corrona^® Psoriasis Registry, a joint collaboration between the National Psoriasis Foundation (NPF) and Corrona, LLC, the leading sponsor of registries in autoimmune and immune-mediated diseases, announces it has expanded into Canada and has enrolled its first Canadian psoriasis patient.

With this expansion, the new Canadian sites and patients join a U.S. network of more than 230 participating dermatology health care providers and 3,700 patients already participating in the Corrona^® Psoriasis Registry.

"We very much look forward to working with Canadian dermatologists and their patients. We anticipate that differences in the U.S. and Canadian healthcare systems will lead to novel insights relating to prescribing patterns and clinical outcomes," said Dr. Jeff Greenberg, chief scientific officer of Corrona.

Launched in 2015, the psoriasis registry has contributed data to multiple research posters, which have been presented at medical conferences around the world. Most recently, Corrona^® Psoriasis Registry data was included in a research article with an accompanying commentary in the Journal of the American Academy of Dermatology.

"We're excited to join the registry and contribute to the growing data collected on safety and effectiveness outcomes," said Dr. Wayne Gulliver, Newlab Clinical Research and professor of Medicine and Dermatology, Memorial University of Newfoundland.

The Corrona^® Psoriasis Registry is the largest, independent registry of psoriasis patients. Created as a commitment to the psoriasis community, the registry's goal is to help researchers compare the safety and effectiveness of approved psoriasis therapies.

To learn more about the Corrona^® Psoriasis Registry and to get involved, visit https://www.corrona.org/registries/psoriasis.

Over the last 50 years, the National Psoriasis Foundation (NPF) has become the world's leading nonprofit patient advocacy organization fighting for individuals with psoriasis and psoriatic arthritis. NPF leads this fight by driving efforts for a cure and improving the lives of the more than 8 million Americans affected by this chronic disease. To date, NPF has funded more than $17 million in research grants and fellowships, and to commemorate 50 years, NPF plans to raise an additional $2 million for early scientific career research programs in 2017 alone. Each year, NPF strives to support, educate and advocate on behalf of more individuals living with or caring for someone with the disease than ever before. As part of that effort, NPF established the Patient Navigation Center to offer personalized assistance to everyone with psoriasis or psoriatic arthritis. Join our community today and help drive discovery and create community for all living with psoriatic disease.

SOURCE National Psoriasis Foundation